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Dietary factors are of paramount importance in the management
and prevention of type 2 diabetes. Despite progress in
formulating evidence based dietary guidance, controversy and
confusion remain. In this article, we examine the evidence for
areas of consensus as well as ongoing uncertainty or controversy
about dietary guidelines for type 2 diabetes. What is the best
dietary approach? Is it possible to achieve remission of type 2
diabetes with lifestyle behaviour changes or is it inevitably a
condition causing progressive health decline? We also examine
the influence of nutrition transition and population specific
factors in the global context and discuss future directions for
effective dietary and nutritional approaches to manage type 2
diabetes and their implementation.
Why dietary management matters but is
difficult to implement
Diabetes is one of the biggest global public health problems:
the prevalence is estimated to increase from 425 million people
in 2017 to 629 million by 2045, with linked health, social, and
economic costs.1 Urgent solutions for slowing, or even reversing,
this trend are needed, especially from investment in modifiable
factors including diet, physical activity, and weight. Diet is a
leading contributor to morbidity and mortality worldwide
according to the Global Burden of Disease Study carried out in
188 countries.2 The importance of nutrition in the management
and prevention of type 2 diabetes through its effect on weight
and metabolic control is clear. However, nutrition is also one
of the most controversial and difficult aspects of the
management of type 2 diabetes.
The idea of being on a “diet” for a chronic lifelong condition
like diabetes is enough to put many people off as knowing what
to eat and maintaining an optimal eating pattern are challenging.
Medical nutrition therapy was introduced to guide a systematic
and evidence based approach to the management of diabetes
through diet, and its effectiveness has been demonstrated,3 but
difficulties remain. Although most diabetes guidelines
recommend starting pharmacotherapy only after first making
nutritional and physical activity lifestyle changes, this is not
always followed in practice globally. Most physicians are not
trained in nutrition interventions and this is a barrier to
counselling patients.4 5 Moreover, talking to patients about
nutrition is time consuming. In many settings, outside of
specialised diabetes centres where trained nutritionists/educators
are available, advice on nutrition for diabetes is, at best, a printed
menu given to the patient. In resource poor settings, when type
2 diabetes is diagnosed, often the patient leaves the clinic with
a list of new medications and little else. There is wide variation
in the use of dietary modification alone to manage type 2
diabetes: for instance, estimates of fewer than 5-10% of patients
with type 2 diabetes in India6 and 31% in the UK are reported,
although patients treated by lifestyle measures may be less
closely managed than patients on medication for type 2 diabetes.7
Although systems are usually in place to record and monitor
process measures for diabetes care in medical records, dietary
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information is often neglected, even though at least modest
attention to diet is needed to achieve adequate glycaemic control.
Family doctors and hospital clinics should collect this
information routinely but how to do this is a challenge.5 8
Progress has been made in understanding the best dietary advice
for diabetes but broader problems exist. For instance, increasing
vegetable and fruit intake is recommended by most dietary
guidelines but their cost is prohibitively high in many settings:
the cost of two servings of fruits and three servings of vegetables
a day per individual (to fulfil the “5-a-day” guidance) accounted
for 52%, 18%, 16%, and 2% of household income in low, low
to middle, upper to middle, and high income countries,
respectively.9 An expensive market of foods labelled for use by
people with diabetes also exists, with products often being no
healthier, and sometimes less healthy, than regular foods. After
new European Union legislation, food regulations in some
countries, including the UK, were updated as recently as July
2016 to ban such misleading labels. This is not the case
elsewhere, however, and what will happen to such regulation
after the UK leaves the European Union is unclear, which
highlights the importance of the political environment.
Evidence for current dietary guidelines
In some, mostly developed, countries, dietary guidelines for the
management of diabetes have evolved from a focus on a low
fat diet to the recognition that more important considerations
are macronutrient quality (that is, the type versus the quantity
of macronutrient), avoidance of processed foods (particularly
processed starches and sugars), and overall dietary patterns.
Many systematic reviews and national dietary guidelines have
evaluated the evidence for optimal dietary advice, and we will
not repeat the evidence review.10-18 We focus instead in the
following sections on some important principles where broad
consensus exists in the scientific and clinical community and
highlight areas of uncertainty, but we begin by outlining three
underpinning features.
Firstly, an understanding of healthy eating for the prevention
and management of type 2 diabetes has largely been derived
from long term prospective studies and limited evidence from
randomised controlled trials in general populations,
supplemented by evidence from people with type 2 diabetes.
Many published guidelines and reviews have applied grading
criteria and this evidence is often of moderate quality in the
hierarchy of evidence that places randomised controlled trials
at the top. Elsewhere, it is argued that different forms of
evidence evaluating consistency across multiple study designs
including large population based prospective studies of clinical
endpoints, controlled trials of intermediate pathways, and where
feasible randomised trials of clinical endpoints should be used
collectively for evidence based nutritional guidance.19
Secondly, it is now recognised that dietary advice for both the
prevention and management of type 2 diabetes should converge,
and they should not be treated as different entities (fig 1).
However, in those with type 2 diabetes, the degree of glycaemic
control and type and dose of diabetes medication should be
coordinated with dietary intake.12 With some dietary
interventions, such as very low calorie or low carbohydrate
diets, people with diabetes would usually stop or reduce their
diabetes medication and be monitored closely, as reviewed in
a later section.
Thirdly, while recognising the importance of diet for weight
management, there is now greater understanding10 of the multiple
pathways through which dietary factors exert health effects
through both obesity dependent and obesity independent
mechanisms. The influence of diet on weight, glycaemia, and
glucose-insulin homeostasis is directly relevant to glycaemic
control in diabetes, while other outcomes such as cardiovascular
complications are further influenced by the effect of diet on
blood lipids, apolipoproteins, blood pressure, endothelial
function, thrombosis, coagulation, systemic inflammation, and
vascular adhesion. The effect of food and nutrients on the gut
microbiome may also be relevant to the pathogenesis of diabetes
but further research is needed. Therefore, diet quality and
quantity over the longer term are relevant to the prevention and
management of diabetes and its complications through a wide
range of metabolic and physiological processes.
Areas of consensus in guidelines
Weight management
Type 2 diabetes is most commonly associated with overweight
or obesity and insulin resistance. Therefore, reducing weight
and maintaining a healthy weight is a core part of clinical
management. Weight loss is also linked to improvements in
glycaemia, blood pressure, and lipids and hence can delay or
prevent complications, particularly cardiovascular events.
Energy balance
Most guidelines recommend promoting weight loss among
overweight or obese individuals by reducing energy intake.
Portion control is one strategy to limit energy intake together
with a healthy eating pattern that focuses on a diet composed
of whole or unprocessed foods combined with physical activity
and ongoing support.
Dietary patterns
The evidence points to promoting patterns of food intake that
are high in vegetables, fruit, whole grains, legumes, nuts, and
dairy products such as yoghurt but with some cautions. Firstly,
some dietary approaches (eg, low carbohydrate diets)
recommend restricting the intake of fruits, whole grains, and
legumes because of their sugar or starch content. For fruit intake,
particularly among those with diabetes, opinion is divided
among scientists and clinicians (see appendix on bmj.com).
Many guidelines continue to recommend fruit, however, on the
basis that fructose intake from fruits is preferable to isocaloric
intake of sucrose or starch because of the additional
micronutrient, phytochemical, and fibre content of fruit.
Secondly, despite evidence from randomised controlled trials
and prospective studies10 that nuts may help prevent type 2
diabetes, some (potentially misplaced) concern exists about
their high energy content. Further research in people with type
2 diabetes should help to clarify this.
There is also consensus on the benefits of certain named dietary
patterns such as the Mediterranean diet for prevention and
management of type 2 diabetes. Expert guidelines also support
other healthy eating patterns that take account of local
sociocultural factors and personal preferences.
Foods to avoid
Consensus exists on reducing or avoiding the intake of processed
red meats, refined grains and sugars (especially sugar sweetened
drinks) both for prevention and management of type 2 diabetes,
again with some cautions. Firstly, for unprocessed red meat,
the evidence of possible harm because of the development of
type 2 diabetes is less consistent and of a smaller magnitude.
More research is needed on specific benefits or harms in people
with type 2 diabetes. Secondly, evidence is increasing on the
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relevance of carbohydrate quality: that is that whole grains and
fibre are better choices than refined grains and that fibre intake
should be at least as high in people with type 2 diabetes as
recommended for the general population, that diets that have a
higher glycaemic index and load are associated with an increased
risk of type 2 diabetes, and that there is a modest glycaemic
benefit in replacing foods with higher glycaemic load with foods
with low glycaemic load. However, debate continues about the
independence of these effects from the intake of dietary fibre.
Some evidence exists that consumption of potato and white rice
may increase the risk of type 2 diabetes but this is limited and
further research is needed.
Moreover, many guidelines also highlight the importance of
reducing the intake of in foods high in sodium and trans fat
because of the relevance of these specifically for cardiovascular
health.
Areas of uncertainty in guidelines
Optimal macronutrient composition
One of the most contentious issues about the management of
type 2 diabetes has been on the best macronutrient composition
of the diet. Some guidelines continue to advise macronutrient
quantity goals, such as the European or Canadian
recommendation of 45–60% of total energy as carbohydrate,
10–20% as protein, and less than 35% as fat,13 20 or the Indian
guidelines that recommend 50-60% energy from carbohydrates,
10-15% from protein, and less than 30% from fat.21 In contrast,
the most recent nutritional guideline from the American Diabetes
Association concluded that there is no ideal mix of
macronutrients for all people with diabetes and recommended
individually tailored goals.12 Alternatively, a low carbohydrate
diet for weight and glycaemic control has gained popularity
among some experts, clinicians, and the public (reviewed in a
later section). Others conclude that a low carbohydrate diet
combined with low saturated fat intake is best.22
For weight loss, three points are noteworthy when comparing
dietary macronutrient composition. Firstly, evidence from trials
points to potentially greater benefits from a low carbohydrate
than a low fat diet but the difference in weight loss between
diets is modest.23 Secondly, a comparison of named diet
programmes with different macronutrient composition
highlighted that the critical factor in effectiveness for weight
loss was the level of adherence to the diet over time.24 Thirdly,
the quality of the diet in low carbohydrate or low fat diets is
important.25 26
Research to date on weight or metabolic outcomes in diabetes
is complicated by the use of different definitions for the different
macronutrient approaches. For instance, the definition of a low
carbohydrate diet has ranged from 4% of daily energy intake
from carbohydrates (promoting nutritional ketosis) to 40%.15
Similarly, low fat diets have been defined as fat intake less than
30% of daily energy intake or substantially lower. Given these
limitations, the best current approach may be an emphasis on
the use of individual assessment for dietary advice and a focus
on the pattern of eating that most readily allows the individual
to limit calorie intake and improve macronutrient quality (such
as avoiding refined carbohydrates).
Fish
Regular fish intake of at least two servings a week, including
one serving of oily fish (eg, salmon, mackerel, and trout) is
recommended for cardiovascular risk prevention but fish intake
has different associations with the risk of developing type 2
diabetes across the world—an inverse association, no
association, and a positive association.27 It is thought that the
type of fish consumed, preparation or cooking practices, and
possible contaminants (eg, methyl mercury and polychlorinated
biphenyls) vary by geographical location and contributed to this
heterogeneity. More research is needed to resolve whether fish
intake should be recommended for the prevention of diabetes.
However, the current evidence supports an increase in
consumption of oily fish for individuals with diabetes because
of its beneficial effects on lipoproteins and prevention of
coronary heart disease. Most guidelines agree that omega 3
polyunsaturated fatty acid (fish oil) supplementation for
cardiovascular prevention in people with diabetes should not
be recommended but more research is needed and the results
of the ASCEND (A Study of Cardiovascular Events in Diabetes)
trial should help to clarify this.28
Dairy
Dairy foods are encouraged for the prevention of type 2 diabetes,
with more consistent evidence of the benefits of fermented dairy
products, such as yoghurt. Similar to population level
recommendations about limiting the intake of foods high in
saturated fats and replacing them with foods rich in
polyunsaturated fat, the current advice for diabetes also favours
low fat dairy products but this is debated. More research is
needed to resolve this question.
Oils
Uncertainty continues about certain plant oils and tropical oils
such as coconut or palm oil as evidence from prospective studies
or randomised controlled trials on clinical events is sparse or
non-existent. However, olive oil, particularly extra virgin olive
oil, has been studied in greater detail with evidence of potential
benefits for the prevention and management of type 2 diabetes29
and the prevention of cardiovascular disease within the context
of a Mediterranean diet30 (see article in this series on dietary
fats).31
Difficulties in setting guidelines
Where dietary guidelines exist (in many settings there are none,
or they are adapted from those in developed countries and
therefore may not be applicable to the local situation), they vary
substantially in whether they are evidence based or opinion
pieces, and updated in line with scientific progress or outdated.
Their accessibility—both physical availability (eg, through a
website or clinic) and comprehensibility— for patients and
healthcare professionals varies. They vary also in scope, content,
detail, and emphasis on the importance of individualised dietary
advice, areas of controversy, and further research needs. The
quality of research that informs dietary guidelines also needs
greater investment from the scientific community and funders.
Moreover, lack of transparency in the development of guidelines
and bias in the primary nutritional studies can undermine the
development of reliable dietary guidelines; recommendations
for their improvement must be heeded.32
Reversing type 2 diabetes through diet
Type 2 diabetes was once thought to be irreversible and
progressive after diagnosis, but much interest has arisen about
the potential for remission. Consensus on the definition of
remission is a sign of progress: glucose levels lower than the
diagnostic level for diabetes in the absence of medications for
hyperglycaemia for a period of time (often proposed to be at
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least one year).33 34 However, the predominant role of energy
deficit versus macronutrient composition of the diet in achieving
remission is still controversial.
Remission through a low calorie energy
deficit diet
Although the clinical observation of the lifelong, steadily
progressive nature of type 2 diabetes was confirmed by the UK
Prospective Diabetes Study,35 rapid normalisation of fasting
plasma glucose after bariatric surgery suggested that
deterioration was not inevitable.36 As the main change was one
of sudden calorie restriction, a low calorie diet was used as a
tool to study the mechanisms involved. In one study of patients
with type 2 diabetes, fasting plasma glucose normalised within
seven days of following a low calorie diet.37 This normalisation
through diet occurred despite simultaneous withdrawal of
metformin therapy. Gradually over eight weeks, glucose
stimulated insulin secretion returned to normal.37 Was this a
consequence of calorie restriction or composition of the diet?
To achieve the degree of weight loss obtained (15 kg), about
610 kcal a day was provided—510 kcal as a liquid formula diet
and about 100 kcal as non-starchy vegetables. The formula diet
consisted of 59 g of carbohydrate (30 g as sugars), 11.4 g of fat,
and 41 g of protein, including required vitamins and minerals.
This high “sugar” approach to controlling blood glucose may
be surprising but the critical aspect is not what is eaten but the
gap between energy required and taken in. Because of this
deficit, the body must use previously stored energy. Intrahepatic
fat is used first, and the 30% decrease in hepatic fat in the first
seven days appears sufficient to normalise the insulin sensitivity
of the liver.37 In addition, pancreatic fat content fell over eight
weeks and beta cell function improved. This is because insulin
secretory function was regained by re-differentiation after fat
removal.38
The permanence of these changes was tested by a nutritional
and behavioural approach to achieve long term isocaloric eating
after the acute weight loss phase.39 It was successful in keeping
weight steady over the next six months of the study. Calorie
restriction was associated with both hepatic and pancreatic fat
content remaining at the low levels achieved. The initial
remission of type 2 diabetes was closely associated with duration
of diabetes, and the individuals with type 2 diabetes of shorter
duration who achieved normal levels of blood glucose
maintained normal physiology during the six month follow-up
period. Recently, 46% of a UK primary care cohort remained
free of diabetes at one year during a structured low calorie
weight loss programme (the DiRECT trial).40 These results are
convincing, and four years of follow-up are planned.
A common criticism of the energy deficit research has been that
very low calorie diets may not be achievable or sustainable.
Indeed, adherence to most diets in the longer term is an
important challenge.24 However, Look-AHEAD, the largest
randomised study of lifestyle interventions in type 2 diabetes
(n=5145), randomised individuals to intensive lifestyle
management, including the goal to reduce total calorie intake
to 1200-1800 kcal/d through a low fat diet assisted by liquid
meal replacements, and this approach achieved greater weight
loss and non-diabetic blood glucose levels at year 1 and year 4
in the intervention than the control group.41
Considerable interest has arisen about whether low calorie diets
associated with diabetes remission can also help to prevent
diabetic complications. Evidence is sparse because of the lack
of long term follow-up studies but the existing research is
promising. A return to the non-diabetic state brings an
improvement in cardiovascular risk (Q risk decreasing from
19.8% to 5.4%)39; case reports of individuals facing foot
amputation record a return to a low risk state over 2-4 years
with resolution of painful neuropathy42 43; and retinal
complications are unlikely to occur or progress.44 However,
other evidence highlights that worsening of treatable
maculopathy or proliferative retinopathy may occur following
a sudden fall in plasma glucose levels,45 46 so retinal imaging in
4-6 months is recommended for individuals with more than
minimal retinopathy if following a low calorie remission diet.
Annual review is recommended for all those in the post-diabetic
state, and a “diabetes in remission” code (C10P) is now available
in the UK.34
Management or remission through a low
carbohydrate diet
Before insulin was developed as a therapy, reducing
carbohydrate intake was the main treatment for diabetes.47 48
Carbohydrate restriction for the treatment of type 2 diabetes has
been an area of intense interest because, of all the
macronutrients, carbohydrates have the greatest effect on blood
glucose and insulin levels.49
In a review by the American Diabetes Association, interventions
of low carbohydrate (less than 40% of calories) diets published
from 2001 to 2010 were identified.15 Of 11 trials, eight were
randomised and about half reported greater improvement in
HbA1c on the low carbohydrate diet than the comparison diet
(usually a low fat diet), and a greater reduction in the use of
medicines to lower glucose. Notably, calorie reduction coincided
with carbohydrate restriction in many of the studies, even though
it was not often specified in the dietary counselling. One of the
more highly controlled studies was an inpatient feeding study,50
which reported a decline in mean HbA1c from 7.3% to 6.8%
(P=0.006) over just 14 days on a low carbohydrate diet.
For glycaemia, other reviews of evidence from randomised trials
on people with type 2 diabetes have varying conclusions.51-56
Some concluded that low carbohydrate diets were superior to
other diets for glycaemic control, or that a dose response
relationship existed, with stricter low carbohydrate restriction
resulting in greater reductions in glycaemia. Others cautioned
about short term beneficial effects not being sustained in the
longer term, or found no overall advantage over the comparison
diet. Narrative reviews have generally been more emphatic on
the benefits of low carbohydrate diets, including increased
satiety, and highlight the advantages for weight loss and
metabolic parameters.57 58 More recently, a one year clinic based
study of the low carbohydrate diet designed to induce nutritional
ketosis (usually with carbohydrate intake less than 30 g/d) was
effective for weight loss, and for glycaemic control and
medication reduction.59 However, the study was not randomised,
treatment intensity differed substantially in the intervention
versus usual care groups, and participants were able to select
their group.
Concerns about potential detrimental effects on cardiovascular
health have been raised as low carbohydrate diets are usually
high in dietary fat, including saturated fat. For lipid markers as
predictors of future cardiovascular events, several studies found
greater improvements in high density lipoprotein cholesterol
and triglycerides with no relative worsening of low density
lipoprotein cholesterol in patients with type 2 diabetes following
carbohydrate restriction,15 with similar conclusions in
non-diabetic populations.57 60-62 Low density lipoprotein
cholesterol tends to decline more, however, in a low fat
comparison diet61 63 and although low density lipoprotein
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cholesterol may not worsen with a low carbohydrate diet63 in
the short term, the longer term effects are unclear. Evidence
shows that low carbohydrate intake can lower the more
atherogenic small, dense low density lipoprotein particles.57 64
Because some individuals may experience an increase in serum
low density lipoprotein cholesterol when following a low
carbohydrate diet high in saturated fat, monitoring is important.
Another concern is the effect of the potentially higher protein
content of low carbohydrate diets on renal function. Evidence
from patients with type 2 diabetes with normal baseline renal
function and from individuals without diabetes and with normal
or mildly impaired renal function has not shown worsening
renal function at one or up to two years of follow-up,
respectively.22 65-67 Research in patients with more severely
impaired renal function, with or without diabetes, has not been
reported to our knowledge. Other potential side effects of a very
low carbohydrate diet include headache, fatigue, and muscle
cramping but these side effects can be avoided by adequate fluid
and sodium intake, particularly in the first week or two after
starting the diet when diuresis is greatest. Concern about urinary
calcium loss and a possible contribution to increased future risk
of kidney stones or osteoporosis68 have not been verified69 but
evidence is sparse and warrants further investigation. The long
term effects on cardiovascular disease and chronic kidney
disease in patients with diabetes need further evaluation.
Given the hypoglycaemic effect of carbohydrate restriction,
patients with diabetes who adopt low carbohydrate diets and
their clinicians must understand how to avoid hypoglycaemia
by appropriately reducing glucose lowering medications. Finally,
low carbohydrate diets can restrict whole grain intake and
although some low carbohydrate foods can provide the fibre
and micronutrients contained in grains, it may require greater
effort to incorporate such foods. This has led some experts to
emphasise restricting refined starches and sugars but retaining
whole grains.
Nutrition transition and population
specific factors
Several countries in sub-Saharan Africa, South America, and
Asia (eg, India and China) have undergone rapid nutrition
transition in the past two decades. These changes have paralleled
economic growth, foreign investment in the fast food industry,
urbanisation, direct-to-consumer marketing of foods high in
calories, sale of ultraprocessed foods, and as a result, lower
consumption of traditional diets. The effect of these factors on
nutrition have led to obesity and type 2 diabetes on the one hand,
and co-existing undernutrition and micronutrient deficiencies
on the other.
Dietary shifts in low and middle income countries have been
stark: in India, these include a substantial increase in fat intake
in the setting of an already high carbohydrate intake, with a
slight increase in total energy and protein,70 and a decreasing
intake of coarse cereals, pulses, fruits, and vegetables71; in China,
animal protein and fat as a percentage of energy has also
increased, while cereal intake has decreased.72 An almost
universal increase in the intake of caloric beverages has also
occurred, with sugar sweetened soda drinks being the main
beverage contributing to energy intake, for example among
adults and children in Mexico,73 or the substantial rise in China
in sales of sugar sweetened drinks from 10.2 L per capita in
1998 to 55.0 L per capita in 2012.74 The movement of
populations from rural to urban areas within a country may also
be linked with shifts in diets to more unhealthy patterns,75 while
acculturation of immigrant populations into their host countries
also results in dietary shifts.76
In some populations, such as South Asians, rice and wheat flour
bread are staple foods, with a related high carbohydrate intake
(60-70% of calories).77 Although time trends show that intake
of carbohydrate has decreased among South Asian Indians, the
quality of carbohydrates has shifted towards use of refined
carbohydrates.71 The use of oils and traditional cooking practices
also have specific patterns in different populations. For instance,
in India, the import and consumption of palm oil, often
incorporated in the popular oil vanaspati (partially hydrogenated
vegetable oil, high in trans fats), is high.78 Moreover, the
traditional Indian cooking practice of frying at high temperatures
and re-heating increases trans fatty acids in oils.79 Such oils are
low cost, readily available, and have a long shelf life, and thus
are more attractive to people from the middle and low
socioeconomic strata but their long term effects on type 2
diabetes are unknown.
Despite the nutrition transition being linked to an increasing
prevalence of type 2 diabetes, obesity and other
non-communicable diseases, strong measures to limit harmful
foods are not in place in many countries. Regulatory frameworks
including fiscal policies such as taxation for sugar sweetened
beverages need to be strengthened to be effective and other
preventive interventions need to be properly implemented.
Efforts to control trans fatty acids in foods have gained
momentum but are largely confined to developed countries. To
reduce consumption in low and middle income countries will
require both stringent regulations and the availability and
development of alternative choices of healthy and low cost oils,
ready made food products, and consumer education.80 The need
for nutritional labelling is important but understanding nutrition
labels is a problem in populations with low literacy or nutrition
awareness, which highlights the need for educational activities
and simpler forms of labelling. The role of dietary/nutritional
factors in the predisposition of some ethnic groups to developing
type 2 diabetes at substantially lower levels of obesity than
European populations81 is poorly researched and needs
investigation.
Conclusion
Despite the challenges of nutritional research, considerable
progress has been made in formulating evidence based dietary
guidance and some common principles can be agreed that should
be helpful to clinicians, patients, and the public. Several areas
of uncertainty and controversy remain and further research is
needed to resolve these. While adherence to dietary advice is
an important challenge, weight management is still a cornerstone
in diabetes management, supplemented with new developments,
including the potential for the remission of type 2 diabetes
through diet.
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Future directions
• Nutritional research is difficult. Although much progress has been made
to improve evidence based dietary guidelines, more investment is
needed in good quality research with a greater focus on overcoming
the limitations of existing research. Experts should also strive to build
consensus using research evidence based on a combination of different
study designs, including randomised experiments and prospective
observational studies
• High quality research is needed that compares calorie restriction and
carbohydrate restriction to assess effectiveness and feasibility in the
long term. Consensus is needed on definitions of low carbohydrate
nutrition. Use of the findings must take account of individual preferences,
whole diets, and eating patterns
• Further research is needed to resolve areas of uncertainty about dietary
advice in diabetes, including the role of nuts, fruits, legumes, fish, plant
oils, low fat versus high fat dairy, and diet quantity and quality
• Given recent widespread recommendations (such as from the World
Health Organization82 and the UK Scientific Advisory Committee on
Nutrition83) to reduce free sugars to under 10% or even 5% of total
energy intake in the general population and to avoid sugar sweetened
drinks, we need targeted research on the effect of non-nutritive
sweeteners on health outcomes in people with diabetes and in the whole
population
• Most dietary guidelines are derived from evidence from Western
countries. Research is needed to better understand the specific
aetiological factors that link diet/nutrition and diabetes and its
complications in different regions and different ethnic groups. This
requires investment in developing prospective cohorts and building
capacity to undertake research in low and middle income settings and
in immigrant ethnic groups. Up-to-date, evidence based dietary
guidelines are needed that are locally relevant and readily accessible
to healthcare professionals, patients, and the public in different regions
of the world. Greater understanding is also needed about the dietary
determinants of type 2 diabetes and its complications at younger ages
and in those with lower body mass index in some ethnic groups
• We need investment in medical education to train medical students and
physicians in lifestyle interventions, including incorporating nutrition
education in medical curricula
• Individual, collective, and upstream factors are important. Issuing dietary
guidance does not ensure its adoption or implementation. Research is
needed to understand the individual and societal drivers of and barriers
to healthy eating. Educating and empowering individuals to make better
dietary choices is an important strategy; in particular, the social aspects
of eating need attention as most people eat in family or social groups
and counselling needs to take this into account. Equally important is
tackling the wider determinants of individual behaviour—the “foodscape”,
sociocultural and political factors, globalisation, and nutrition transition
Key messages
• Considerable evidence supports a common set of dietary approaches
for the prevention and management of type 2 diabetes, but uncertainties
remain
• Weight management is a cornerstone of metabolic health but diet quality
is also important
• Low carbohydrate diets as the preferred choice in type 2 diabetes is
controversial. Some guidelines maintain that no single ideal percentage
distribution of calories from different macronutrients (carbohydrates,
fat, or protein) exists, but there are calls to review this in light of emerging
evidence on the potential benefits of low carbohydrate diets for weight
management and glycaemic control
• The quality of carbohydrates such as refined versus whole grain sources
is important and should not get lost in the debate on quantity
• Recognition is increasing that the focus of dietary advice should be on
foods and healthy eating patterns rather than on nutrients. Evidence
supports avoiding processed foods, refined grains, processed red meats,
and sugar sweetened drinks and promoting the intake of fibre,
vegetables, and yoghurt. Dietary advice should be individually tailored
and take into account personal, cultural, and social factors
• An exciting recent development is the understanding that type 2 diabetes
does not have to be a progressive condition but instead there is potential
for remission with dietary intervention
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Figure
Fig 1 Dietary advice for different populations for the prevention and management of type 2 diabetes
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